Since 1996, Mr. Starks has been a member of the board of directors. From 2004 to 2015, he held the positions of chairman of the board, president, and chief executive officer. He was appointed executive chairman in January 2016.
Mr. Starks served as president and chief executive officer of Daig Corporation, a producer of specialized cardiovascular equipment that St. Jude Medical purchased in 1996, before joining the company.
Mr. Starks was appointed president and chief operating officer of the company in 2001 after being designated president and chief executive officer of the St. Jude Medical cardiac rhythm management division in 1998.
Under Mr. Starks’ direction, the company’s revenue increased from $2.3 billion in 2004 to $5.5 billion in 2015, and it had one of its most successful fiscal years (on adjusted earnings per share basis) ever in 2015.
In addition to having extensive knowledge of the business, strategy, people, operations, and financial situation of the organization, Mr. Starks offers to the board of directors over 30 years of expertise in the medical device industry.
Additionally, Mr. Starks offers a global network of connections with clients, businesses, and other important stakeholders.
What is Daniel Starks Net Worth?
As of May 3, 2022, Daniel J. Starks’ estimated net worth is at least $747 million. Over the past five years, Mr. Starks has sold shares of Abbott Laboratories valued at over $5,661,000 while owning over 50,000 units of the company’s stock, which is worth over $740,585,700.
He also receives $300,910 from Abbott Laboratories as an Independent Director.